相关实验视频
Updated: Jul 6, 2025

05:18
A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
Published on: February 17, 2023
3.9K
1型糖尿病中的糖尿病条纹病:一种罕见的难题
Vijayakumar Karthik1, Puthiyaveetil Khadar Jabbar2, Abilash Nair2
1Endocrinology, Government Medical College Thiruvananthapuram, Thiruvananthapuram, Kerala, India kannanhbk91@gmail.com.
BMJ case reports
|December 30, 2023
概括
糖尿病条纹病,一种与糖尿病相关的运动障碍,在1型糖尿病中很少见. 这一案例突出了一个患有1型糖尿病的年轻患者,由于血糖失控而经历了 Hemichorea-hemiballism.
科学领域:
- 神经学 神经学
- 内分泌学 在内分泌学.
- 放射学 放射学是一门学科.
背景情况:
- 糖尿病条纹病是一种超运动运动障碍综合征 ( Hemichorea-hemiballism) 与基底腺异常相关.
- 神经成像发现可以模仿脑出血,可能导致误诊.
- 这种情况通常在患有2型糖尿病的老年患者中观察到,在1型糖尿病中很少发生.
研究的目的:
- 报告一种罕见的糖尿病条纹病例,发生在患有1型糖尿病的年轻人身上.
- 详细介绍这个不寻常的病例的临床表现,生化和放射学发现.
- 强调认识到糖尿病条纹病的重要性,以准确诊断和管理.
主要方法:
- 病例报告详细介绍了一名患有1型糖尿病的年轻男性患者.
- 对高动力运动障碍 ( Hemichorea-hemiballism) 的临床评估.
- 对神经成像 (CT/MRI) 和生化研究的审查.
- 治疗和结果的文件.
主要成果:
- 这位患者出现了急性发病的半球核-半球体,影响左上下肢.
- 神经成像显示了与糖尿病条纹病变相一致的基底腺异常.
- 这种情况与一个年轻的1型糖尿病患者的血糖水平失控有关.
结论:
- 糖尿病条纹病可能发生在患有1型糖尿病的年轻人中,特别是血糖控制不良的人.
- 对这种临床放射性综合征的认识至关重要,以避免误诊和不必要的调查.
- 早期识别和适当的管理可以改善患者的治疗结果.
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
549
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
549
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Pathophysiology of Diabetes
941
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
941
Carbohydrate Metabolism
11.1K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.1K
Diabetes: Management and Pharmacotherapy
285
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
285

